September 16, 2011: ACTTION Awarded 5-Year Grant From FDA

ACTTION is pleased to announce that it has received a 5-year research grant from the FDA with up to $4.5 million in funding to support its activities. Extending the FDA’s initial research contract (awarded in September 2010), this new research grant reflects the FDA’s continued support for ACTTION and constitutes a critical long-term commitment to the success of the ACTTION public-private partnership. The University of Rochester press release describing the research grant award can be found here.

News

ACTTION Guide to Clinical Trials of Pain Treatments

The ACTTION Guide to Clinical Trials of Pain Treatments consists of two supplements published in the journal Pain Reports that include a series of articles describing research designs and methods, study conduct, outcome measures, data analyses and interpretation, and reporting recommendations for clinical trials of acute and chronic pain treatments.

Part I includes 9 articles that can be found here, and Part II includes 6 articles that can be found here.